Aller au contenu

Efficacy of maintenance olaparib for patients with newly diagnosed advanced ovarian cancer with a BRCA mutation: subgroup analysis findings from the SOLO1 trial

Nom du journal : J Clin Oncol

Année : 2020

Volume : 38

Page de départ : 3528

Page de fin : 3537

Auteurs: DiSilvestro P, Bloomfield R, Lowe ES, Oza A, Banerjee S, Gourley C, Lisyanskaya A, Oaknin A, Moore KN, Liu J, Leary A, Kim BG, Colombo N, Sonke GS, Friedlander M, Scambia G, Floquet A, González-Martín A, Aghajanian CA, Bradley WH, Mathews CA,